FREE CONSULT

No Fees Unless You Collect

Kirkland Advises GTCR on Strategic Majority Investment in Biocoat

Kirkland & Ellis advised GTCR on its strategic, majority investment in Biocoat Holdings, LLC (Biocoat), a leading medical device contract manufacturing organization. As part of its Leaders Strategy™ to find and partner with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions, GTCR will partner with industry veteran Chip Hance, the current Chairman of GTCR portfolio company Regatta Medical Holdings, LLC (d/b/a Resonetics), who will join Biocoat as Executive Chairman. Going forward, the existing Biocoat management team, led by CEO Jim Moran, will continue in their existing roles executing on Biocoat’s growth initiatives in partnership with GTCR.

Powered by WPeMatico

Related Posts

Call Now
Directions